6 полученные результаты
FIELD OF THE INVENTION
The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of
FIELD OF THE INVENTION
The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of
BACKGROUND ART
Magnesium (Mg) is the second most abundant cation in the body [Altura, B. M. et al., Drugs 28 (Suppl.I):120-142, 1984]. It is cofactor for more than 325 cellular enzymes involved in cellular energy production and storage, protein synthesis, DNA and RNA synthesis, cell growth and
FIELD OF THE INVENTION
This invention relates to magnesium-based compositions for treating migraine headaches, and methods for using the same.
BACKGROUND OF THE INVENTION
Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the gastric
FIELD OF THE INVENTION
This invention relates to magnesium-based analgesic compositions for treating migraine headaches, and methods for using the same.
BACKGROUND OF THE INVENTION
Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 371 of PCT/KR2010/007845, filed Nov. 8, 2010, which claims the benefit of Korean Patent Application No. 10-2009-0106912, filed Nov. 6, 2009, the entire contents of each of which are incorporated herein by reference.
TECHNICAL FIELD
The